GCG and obesity disorder: In addition, in vitro SCFA promote GLP-1 cell differentiation and GLP-1 release in mouse and human enteroids [66] and stimulate GLP-1 and PYY secretion via their action on FFAR2 [117,118], resulting in improved glucose tolerance and in prevention of obesity development [118,119].